EBITDA

Revenue declined 6.0 per cent YoY to Rs 11.1bn with hospitals declining 0.6 per cent, diagnostics dropping 8.0 per cent

EBITDA was at Rs 1,555 Crore, up 13 per cent YoY with margin at 27.2 per cent, as compared with 25.7 per cent in FY19

Ironically, if the regulations caused strife in the last two years, the main fillip in the next two years is expected to come from…

Aggregate revenues of companies grew by ~14 per cent on a Y-o-Y basis, from Rs4,206 crore in Q2 FY2019 to Rs4,807 crore in Q2…

Consolidated income from operations was Rs2,785 mn compared to Rs2,453 mn in corresponding quarter of previous year, reflecting…

The company recorded a net profit of Rs 24.7 crore for quarter ending June 30, 2019 before impact of Ind AS 116

Tough days were triggered on account of several regulatory measures, including cap on prices of stents by National Pharmaceutical…

Ameera Shah, Managing Director, Metropolis Healthcare, reveals more about the company’s plan post IPO, in an interaction with…

In 9MFY19, revenue from operations improved by 17 per cent to ₹ 5,762 crore